Missouri's AI Mental Health Ad Ban Takes Effect Soon

The landscape for artificial intelligence in healthcare is rapidly evolving, and Missouri is taking a definitive stance. With just days until August 28, 2026, a new state Act will fundamentally change how AI tools can be marketed and represented in the sensitive field of mental health.

What's changing — substance.

Missouri's Senate Bill 1019, titled "Modifies several provisions relating to health care," is set to become effective on August 28, 2026. This pivotal Act introduces critical restrictions on how artificial intelligence can be advertised and represented, specifically within the realm of mental health services.

At its core, SB 1019 prohibits companies and individuals operating within Missouri from advertising or claiming that an artificial intelligence system can function as a mental health professional or provide therapy services. This means any public-facing claims that an AI can offer therapy, psychotherapy, or a mental health diagnosis are explicitly banned. The legislation doesn't delve into a broad definition of AI itself, but rather zeroes in on these specific, prohibited actions, aiming to safeguard consumers from potential deception and ensure that mental health care remains firmly within the domain of licensed human professionals.

The journey of SB 1019 through the legislative process saw its introduction in the Senate on January 15, 2026, followed by passage in the Senate on March 12, 2026. It then moved to the House, where it had its first reading on March 12, 2026, and was truly agreed to and finally passed on May 15, 2026. The Act was delivered to the Governor on May 28, 2026, and now, its effective date is fast approaching.

A crucial aspect of this new Act is its enforcement mechanism. Violating SB 1019 is classified as an "unlawful practice" under Missouri's existing consumer protection statutes. This strategic approach means the state's Attorney General will be responsible for enforcement, leveraging established legal frameworks rather than creating entirely new regulatory bodies for AI. This integration streamlines the enforcement process but also places AI-related claims under the stringent scrutiny of deceptive trade practices law.

The financial implications for non-compliance are significant. Companies or individuals found in violation face a civil penalty of $10,000 for a first offense. Subsequent violations will incur a steeper penalty of $20,000 each. These penalties underscore the state's commitment to preventing misleading representations in such a critical sector.

It's important to clarify what this Act doesn't do. SB 1019 is not a blanket ban on the use of AI tools in mental health. Instead, it specifically targets misleading advertising and public representations. Companies that utilize AI to assist licensed mental health professionals – for instance, for administrative tasks, data analysis, or providing supplementary information – may still operate compliantly, provided they clearly disclose the AI's supportive role and do not present it as an independent therapist or diagnostician. The distinction lies in the public claim of autonomy and professional capability.

Who is affected — jurisdictions, sectors, sizes.

This new Missouri Act has a broad reach, impacting any entity or individual involved in the development, deployment, or marketing of artificial intelligence solutions within the state, particularly those touching upon mental health services.

Jurisdictionally, the focus is squarely on Missouri. Any company, regardless of its primary location, that advertises or makes claims about AI's mental health capabilities to consumers or entities within Missouri must comply. This includes developers, distributors, and service providers whose AI products or platforms are accessible or marketed in the state.

Sector-wise, the primary impact will be felt across several interconnected industries. This includes the burgeoning healthcare technology sector, especially companies specializing in digital health, telehealth, and AI-driven wellness platforms. AI development firms creating algorithms or applications with potential mental health applications will need to scrutinize their outward-facing communications. Furthermore, mental health service providers themselves, if they integrate or endorse AI tools, must ensure their own messaging aligns with the Act's prohibitions. Even advertising and marketing agencies working with clients in these spaces will need to be acutely aware of the new rules to avoid creating non-compliant campaigns.

In terms of size, the Act makes no distinctions. From small startups innovating in the AI space to large, established corporations with extensive product lines, and even individual practitioners or developers, all are subject to the same compliance obligations and potential penalties. The emphasis is on the action of making prohibited claims, not the scale of the entity making them. Essentially, if you're making public representations about AI acting as a mental health professional or providing therapy in Missouri, this Act applies to you.

Three things to do this week — concrete actions.

With the August 28, 2026, effective date just around the corner, companies and individuals operating in Missouri need to take immediate steps to ensure compliance with Senate Bill 1019. Proactive measures now can prevent significant civil penalties and reputational damage later.

1. Conduct a Comprehensive Review of All Marketing and Public-Facing Materials: Scrutinize your websites, social media channels, brochures, press releases, product packaging, and any other advertising content. Specifically, look for any language that suggests your AI system acts as a "mental health professional," provides "therapy services," "psychotherapy services," or offers a "mental health diagnosis." Any such claims must be immediately revised or removed to align with the Act's prohibitions. This review should extend to third-party distributors or partners who market your AI products in Missouri.

2. Audit Product Descriptions and User Interfaces for Clarity: Beyond external marketing, examine how your AI-powered mental health tools are described within your product documentation, user manuals, and the user interface itself. Ensure that the role of AI is clearly articulated as an assistive technology, supporting human professionals or providing general wellness information, rather than acting as an autonomous therapist or diagnostician. Disclosures should be prominent, emphasizing that the AI is not a substitute for professional human judgment or care.

3. Implement Training for Sales, Marketing, and Product Development Teams: Educate all relevant personnel on the specifics of SB 1019. Sales teams need to understand what claims they can and cannot make during client interactions. Marketing teams must be fully aware of the prohibited language for campaigns. Product development teams should understand the legal boundaries when designing features and describing their capabilities. Ongoing training will help embed these compliance requirements into your organizational culture and prevent inadvertent violations.

Related context — cross-link to other regulations briefly.

Missouri's Senate Bill 1019 is part of a growing national trend where states are actively addressing the implications of artificial intelligence in healthcare, particularly in sensitive areas like mental health. This legislative activity reflects a broader concern about consumer protection, ethical AI deployment, and maintaining professional standards.

For instance, Tennessee has also enacted legislation, AN ACT to amend Tennessee Code Annotated, Title 33; Title 47 and Title 63, relative to mental health (/regulations/RAI-US-TN-SB15800-2026), indicating a similar focus on mental health provisions. In Colorado, a bill concerning the use of artificial intelligence in health care (/regulations/RAI-US-CO-HB26113-2026) signals a broader approach to AI's role across the healthcare spectrum. Similarly, Utah introduced H.B. 452 Artificial Intelligence Amendments (/regulations/RAI-US-UT-H4AIAXX-2025), demonstrating legislative efforts to adapt existing laws to the realities of AI. These examples highlight that while Missouri's Act is specific, it operates within a dynamic and evolving regulatory landscape that demands continuous vigilance from AI developers and healthcare providers nationwide.

Note: this article was drafted by AI - Google Gemini